Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. | Director | Common Stock | 49K | $330K | $6.74 | May 8, 2024 | Direct |
FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
aTYR PHARMA INC | Director | Common Stock | 56K | $98K | $1.75 | May 30, 2024 | Indirect |
aTYR PHARMA INC | Director | Stock Option (right to buy) | 24K | May 22, 2024 | Direct | ||
Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FATE | FATE THERAPEUTICS INC | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
LIFE | aTYR PHARMA INC | May 30, 2024 | 1 | $87.5K | 4 | Jun 3, 2024 | Director |
LIFE | aTYR PHARMA INC | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
TVTX | Travere Therapeutics, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
FATE | FATE THERAPEUTICS INC | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
LIFE | aTYR PHARMA INC | May 17, 2023 | 3 | $0 | 4 | May 19, 2023 | Director |
TVTX | Travere Therapeutics, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
LIFE | aTYR PHARMA INC | Apr 26, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 3, 2022 | 1 | -$32.8K | 4 | Jun 6, 2022 | Director |
TVTX | Travere Therapeutics, Inc. | May 11, 2022 | 2 | $0 | 4 | May 12, 2022 | Director |
LIFE | aTYR PHARMA INC | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
TVTX | Travere Therapeutics, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |